SpeeDx announced recentlythat it has raised a total of $15 million from a US investment group.The Sydney, Australia-based molecular diagnostics developer said it had raised up to $10 million in additional equity investment from US-based Nort... Read More >

The FDA has cleared Drawbridge Health’s blood collection device designed to help monitor long-term blood sugar levels in people with diabetes, which the company describes as easier and less painful than a hypodermic needle. ... Read More >

Abbott Laboratories could have the golden touch when it comes down to detecting traumatic brain injuries (TBI). A new study shows the Abbott Park, IL-based company’s blood test, which is still under development, could help detect mild TBIs... Read More >

Abbott Laboratories has developed a portable tool to help law enforcement agencies crack down on people driving under the influence. The Abbott Park, IL-based company looks to expand the reach of the diagnostic tool – SoToxa Mobile Test Sy... Read More >

Roche has expanded the Global Access Program, originally established to increase availability of HIV diagnostics in underserved countries, to include diagnostic tests for tuberculosis, hepatitis, and human papillomavirus (HPV). Increased acc... Read More >

Life science reagents and tools company Abcam announced today that it has acquired genome editing technologies firm EdiGene's live cell line and lysates portfolio.... Read More >

A federal judge will limit 10x Genomics' ability to sell and market its single-cell analysis solution. Read More >

Agilent Technologies said today that it has agreed to acquire privately held life science instrumentation manufacturer BioTek Instruments for $1.17 billion in cash.... Read More >

Thermo Fisher Scientific today reported a 4 percent increase in second-quarter revenues, driven by growth across its business segments. Read More >

Qiagen on Wednesday afternoon reported preliminary second quarter financial results ahead of its full Q2 earnings release next week, and said that it is adjusting its full-year financial targets downward due to lower-than-expected sales of i... Read More >